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Induction of immune cell infiltration into murine SCCVII tumour by
Photofrin-based photodynamic therapy
G Krosll, M Korbelik' and GJ Dougherty2
'Cancer Imaging and 2Terry Fox Laboratory, British Colwnbia Cancer Research Centre, Vancouver, BC, Canada.
Smay Cdlular populatin in the squamous cell carcinom SCCVH, growing in C3H/HeN mice given
Photofrin, were eamine at various time mtervals during the photodynamic lght treatment and up to 8 h
later. Cel populations present within excised tumours were identified by monodonal antibodies directed
against cell type-specific membrane markers using a combination of the irect immunoperoxidase and
Wright staining or by flow cytometry. Photofrin-based photodynamic therapy (PDT) ihced dramatic
changes in the klv of different ceflular populations contained in the treated tumour. The most pronounced
was a rapid the content of neutrops which ica within 5 min after the initiation of
light treatment. This was followed imiately by an increase in the kvels of mast celk, while another type of
myreoid cells, most likely monocytes, invaded the tumour between 0 and 2 h after PDT. The examiation of
cytolysis of in vito cultured SCCVII tumour cels ted by macrophages harvested from the SCCVII
tumour revealed a pronounced crase in the tumoaicial actity of tumnour-assocated macrophages isolated
at 2 h post PDT. It so, therefore, that the PDT-idhiced acute inflammatory infiltration of mynloid cells
into the treated tumour is assoaated with functional activation of immune cels
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tumour infiltration
A combined effect of several cancer tissue-destroying
mechanisms is responsible for tumour n following
photodynamic therapy (PDT). In addition to direct killing of
tumour cells by phototoxic action and ischaemic necrosis
secondary to the collapse of the vascular system, there are
indications of the involvement of PDT-induced immune reac-
tion (Bellnier and Henderson, 1992; Pass, 1993). The under-
standing of this rather complex interaction of participating
processes is made more difficult by the fact that the events
kading to the vascular damage are different with different
photosensitisers (Henderson and Fingar, 1994).
The most abundant lesion induced in PDT-treated tumours
is phototoxic damage to the surface membranes of tumour
cells. We have hypothesised that this subtle initial and not
nessarily lethal damage may trigger a chain of events
lading to tumour eradication (Korbelik and Krosl, 1994).
The invoked damage is probably the peroxidation of mem-
branous lipids (Thomas et al., 1987), which prompts a rapid
(<1 min) activation of membranous phospholipases (Agar-
wal et al., 1993) for accelerated degradation of phos-
pholipids. It should be noted that very similar events occur in
cell membranes with the initiation of inflammation by mic-
robial infection or by some other types of tissue injury
(Chien et al., 1978; Yamamoto and Ngwenya, 1987). The
membrane damage discussed above can be thus descmbed as
PDT-induced inflammatory cellular dama.
Inflammatory immune resonses induced in caerous tis-
sues may be of a different nature and more intense than
those induced in norml issues (Yamamoto and Ngwenya,
1987); this may very well be the case with the reaction
triggerd by PDT in solid tumours. The lipid composition of
tumour cell membranes is different from that of normal cell
membranes (Snyder and Wood, 1969; Howard et al., 1972).
Fragments released from tumour cell membranes damage
by PDT include a variety of lysophospholipids and alkyl-
glycerols (Yamamoto et al., 1988, 1992), as well as ara-
chidonic acid and its metabolites (Henderson and Donovan,
1989; Belnier and Henderson, 1992; Fingar et aL, 1992), all
of which can serve as highly potent stimulatory signals for
the amplification of the infammatory reaction. They are
powerful chemotactic and stimulatory agents for immune
cells or highly active vasomodulatory mediators (Zurier,
1982; Yamamoto and Ngwenya, 1987; Yamamoto et al.,
1988). A strong inflammatory reaction may be the most
important contributor to the destruction of vasculature in
PDT-treated tumours.
Very high doses of inflammatory products of cancerous
tissues can cause immunosuppression, which was observed
following PDT (Lynch et al., 1989). On the other hand, at
different dose klvels these same agents cause immune stimula-
tion (Ngwenya and Yamamoto, 1986; Yamamoto and
Ngwenya, 1987). It is therefore of critical importance to
better understand the PDT-induced inflammatory/immune
reaction in order to develop improved strategies for
themapeutic benefit.
The accumulation of inflammatory cells is a central event
in the inflammatory process. Yet, there is very lttle inform-
ation available on the infiltration of these cells into the
treated tumour during and after photodynamic light delivery.
Obtaining this information was the main objective of this
study. Focusing on the cinically establshed photosensitiser
Photofrin, we have chosen as tumour model the squamous
cell carcinoma SCCVII growing subcutaneously in the C3H/
HeN mouse. The photodynamic light treatment was per-
formed 24 h after the administration of Photofrin. The
results demonstrate a rapid, massive and regulated infil-
tration of various immune cells into the tumour site during
and imiately following PDT.
Materias ad ncthos
Tumour model
Female C3H/HeN mice, age 10-12 weeks, were used for
experiments. The SCCVII squamous cell carcinoma was
maintained by intramuscular passage as described previously
(Korbelik, 1993). This is a weakly immunogenic tumour
which orig ted spontaneously in the abdominal wall of a
C3H mouse (Olive et al., 1985). For experiments, tumours
were induced by injecting 3 x 10' cells, obtained by
enzymatic digestion of intramusularly growing tumour, sub-
cutaneously over the sacral regon of the back of anaes-
theised mice. Prior to tumour inoculation all the hair was
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removed from the injection site by shaving. Tumours were
used for experiments 2 weeks after the inoculation, at which
point their largest diameter was 7-8 mm and thickness
3-4mm.
Photodynanic therapy
Photofrin (QuadraLogic Technologies Phototherapeutics,
Vancouver, BC, Canada) was administered at 25 mgkg-'
intravenously 24 h before light treatment. A tunable light
source (Photon Technology International, Model A5000)
equipped with a 1 kW xenon arc bulb and infrared filter was
used to deliver 630 ± 10 nm light to the tumour by a liquid
light guide (Oriel, Stratford, CT, USA) with a 5 mm core
diameter. The output light power was 35 mW. Mice were
restrained unanaesthetised in specially designed hoklers. A
dose of 60J cm-2 (average fluence rate 45 mWcm-) was
used in all experiments and the average treatment time was
24mi; the exception were tumours analysed for the effects
occurring before the full light dose was delivered. Tumour
temperature masued using a hypodermic thermocouple
(YSI, Yellow Springs, OH, USA) increased to 38-39'C at
the end of the light treatment.
Indirect immunoperoxidase and Wright staining
At various times after light treatment, mice were sacrificed by
cervical dislocation, tumours excised and minced using two
scalpels. Tumour tissue was then enzymatically dissociated by
a 30 mm treatment in a mixture of dispase, collagenase and
DNAse as described in detail previously (McBnde et al.,
1992; Korbelik, 1993). The resulting cell suspension was
filtered through a 100 jm nylon mesh to remove any remain-
ing tissue clumps and washed with Eagle's minimum essential
medium (EMEM) containing 10% fetal bovine serum (FBS;
HyClone Laboratories, Logan, UT, USA).
Acetone-fixed cytospin preparations of cell suspensions
were stained for CD45 (panleucocyte marker), F4/80 (marker
for mature macrophages) and 41CR (T-lymphocyte marker)
using an indirect immunoperoxidase technique as previously
described (Dougherty et al., 1986). Hybridoma supernatants
containing the monoclonal antibodies YEI.21 directed
against the T-200 antigen (CD45) and HB218 directed
against SCR were generously provided by Dr F Takei
(Terry Fox Laboratory). Hybridoma cells HB 198 producing
the antibody against F4/80 antigen were obtained from the
American Type Culture Collection. All of these were rat
anti-mouse monoclonal antibodies. The secondary antibody
used was a rabbit anti-rat IgG F(ab% fragment conjugated
with horseradish peroxidaw (Sigma, St Louis, MO, USA). At
least 200 positive cells were scored on each slide.
The levels of neutrophils and mast cells were determined
using Wright stain (Accustain, Sigma). For this purpose,
lOjid of a suspension which contained 5 x 104 cells was
layered onto glass slides (three slides per sample), which were
left to dry in air before Wright staining.
Identification ofblood-derived twnour-infiltrating cells
The bisbenzimide dye Hoechst 33342 (Hoechst) purchased
from Sigma was used to identify newly infiltrated leucocytes
in tumours exposed to PDT. Since this fluorescent nuclear
stain is cleared rapidly from the plasma of mice following
intravenous administration (Olive et al., 1985), it is possible
to prevent the blood flow through the tumour for the time
needed for the dye to disappear from the cirulation.
Tumour-bearing mice injeted with Hoechst (16mgkg-1,
i.v.) were divided into two groups. In the first group, the
tumours were clamped before the injection to prevent
Hoechst from reaching the tumours. In the second group, the
tumours were not clamped. The clamp was roved after
10 min to allow reperfusion of the tumour. Half of the mice
from each group were exposed to photodynamic light treat-
ment at 30 min after the Hoechst injection. The mice were
sacrificed at 2 h after the termination of light treatment, the
tumours were excised and disaggregated into single-cell
supensons as described above. The cells were then stained
with monoclonal antibody to mouse CD45, or a combination
of anti-mouse Grl (myeloid marker) and F4/80.
The antibodies to CD45 and Grl, labellW with phyco-
erythin (PE), were purchased from PharMngen (San Diego,
CA, USA), while fluorescein isothiocyanate (FITC)-con-
jugated anti-F4/80 was obtained from Serotec Canada
(Toronto, Ontario, Canada). The staining was performed
using a modification of the procedure described previously
(Dougherty et al., 1989). Each sample (total volume 100IlI)
contained 0.5-1 x 106 cells suspended in Hank's balanced
salt solution (HBSS, Sigma) supplemented with 2% FBS, to
which the antibodies were added at a dilution recommended
by the supplier. The samples, kept in subdued light, were
incubated on ice (0-C) for 30 min. The cells were then
washed twice in HBSS + 2% FBS using centrifuigation. For
&ach sample, 10' cells were analysed by flow cytometry on a
Coulter Epics Elite ESP apparatus (Coulter Ekctronics). The
488 nm laser was used to excite FITC and PE. The enission
of FITC and PE was recorded through 530 ± 15 and
580 ±10 nm bandpass filters respectively. Hoechst was
excited by the UV laser and its fluorescence measured
through a 449 ± 5 nm bandpass filter. Light scatter signals
(forward and side scatter) were also recorded and used for
gating out dead cells, erythrocytes and debris.
The PDT-treated cells of SCCVH tumour have shown
decreased autofluorescence in the 530-580 m region com-
pared with non-treated cells. As the cells die, their forward
light scatter signal will drop substantially. We have not seen
any significant difference in the staining signal (Hoechst,
FITC or PE fluorescence intensity) between the cells from a
non-treated tumour and those cells from PDT-treated
tumours that still show the forward scatter signal within the
values for alive cells (although some of them will eventually
die).
The objective of the above-described flow cytometry
analysis, indirect immunoperoxidase and Wright staining was
to identify and determine the levels ofmajor cellular popula-
tions contained in SCCVII tumour. The total yield of viable
cells per gram of tumour tissue was determined im atel
after the single-cell suspension was obtained from previously
weighed tumour tissue. The cells were counted using a
haemocytometer, with trypan blue staining used to eliminate
dead cells. Yields of individual cell populations were cal-
culated from their relative shares in the tumour cell suspen-
sion. The determination of the levels of mast cells (and in
some cases neutrophils), whose incidence was very low, was
based on scoring on average 1.5 x 105 cells per sample. This
was facilitated by depositing a known number ofcells on the
glss slide, and it was therefore not necessary to count the
cells that were not mast cells (or neutrophils).
Macrophage cytotoxicity against twnour cells
The target cells were obtained from an enzymatically digested
SCCVII tumour and cultivated in vitro for 2-3 weeks, which
resulted in the eimination of non-malignant cells from the
culutre. The growth medium was RPMI-1640 (HyClone) sup-
plmented with 10% FBS. The cells were labelled by
exposure to [H-methyljthymidine (2.0Cimmol', NEN, Du
Pont Canada) at 2pCimlY' for 24h in cell growth medium.
Next, they were washed twice with cell growth medium and
left to incubate further at 3TC to facilitate elimination ofthe
radioactive label from the cytoplasm. Actinomycin D (Sigma)
was added 2h later in a final concentration of 1.5pgml-'.
Four hours later, the cells were washed, trypsinised and
transferred into a 24-well plate (Falcon 3047, Becton Dickin-
son, Lincoln Park, NJ, USA), where they were admixed with
the effector cells.
Macrophages from PDT-treated and non-treated SCCVII
tumours were harvested using a modification of the
differential attachment procedure described previously (Kor-
belik et at., 1991). A known number of cells obtained by the
above-described enzymatic dissociation of tumour tissue(suspended in RPMI-1640 + 10% FBS) were transferred into
the wells of a 24-well plate and incubated for 30 min at 37C.
The medium was then collected, the attached cells overlaid
with 0.5 ml of trypsin-EDTA solution (Sigma) and in-
cubated for 30 s at room temperature. After that, the tryp-
sin-EDTA solution was collected and the wells were washed
vigorously three times with 1 ml of HBSS. The washout
containing removed cells was collected each time. The
number of tumour-associated macrophages (TAMs) isolated
by this procedure (cells remaining in the wells) was deter-
mined by subtracting the number of cells removed by
washings from the number of plated cells. Before admixing
the target cells, the effector cells were incubated with
lipopolysaccharide (LPS) from Escherichia coli 0.11:B4
(Sigma) at 0.1 tg ml-' in RPMI-1640 + 10% FBS for 24 h.
The FBS used in these experiments was decomplemented by
30 min heating at 56°C. The effector and target cells were
admixed at a 20:1 ratio, each well containing 2 x 10' TAMs
and 1 x I0 tumour cells. All testing was done in quadrup-
licate (four wells for each TAM population).
The plates with effector and target cells were incubated for
72 h at 37°C, before the supernatants were collected from the
wells and radioactivity counted using an LKB 1214 liquid
scintillation spectrometer. The total radioactivity incor-
porated into the target cells was determined from the cells
transferred directly into the scintillation vials. Spontaneous
release of [3'Hthymidine from the target cells (in the absence
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of effector cells) was determined for each group of samples;
its levels ranged between 10% and 15%. This value was
subtracted from the experimental release in the calculation of
the percentage of [3H]thymidine release from the target cells
caused by the effector cells. This assay is described in more
detail elsewhere (Korbelik and Krosl, 1994).
The data presented in this work are based on the analysis
of at least six identically treated tumours.
Results
Changes in tumour cellular content
Mice bearing SCCVII tumours were given Photofrin
(25mg kg-', i.v.) and the tumours were irradiated with red
light (60 J cm-2) 24 h later. This PDT treatment results in the
average tumour cure rate of 18% (Krosl and Korbelik,
1994). The effect of such treatment on the cell content of the
SCCVII tumour is shown in Figure 1. Indirct immuno-
peroxidase staining with monoclonal antibodies was used to
identify the malignant cell population (CD45-), TAMs (F4/
80+) and T cells (<$TCR+). The remaining immune cells
infiltrating the SCCVII tumour were described as 'other
myeloid cells', most, but not all of these, stained positively
for the Macl myeloid marker, and appeared by mor-
phological criteria to be members of the monocytic lineage. It
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Fge 1 Levels of major cellular populations in SCCVII tumour before and after PDT. The mice were sacrificed at various time
intervals relative to the PDT treatment (Photofrin 25 mgkg-', 60 J cm-' light), and the cells dissociated from the tumours were
analysed by indirect immunoperoxidase staining, except for neutrophils, which were determined in Wright-stained preparations.
The pie graphs depict the relative contributions of the examined cell populations in control tumours and tumours excised either
immediately or 4 h after the termination ofphotodynamic light treatment. The data are average values from a group of six or more
identically treated mice. The bars show s.d.PDTmd ~m bednd WbdsN.- 00%2 G Kmi eti
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should be noted that the neutrophils ocsionally present in
these slides were not included in the analysis. We have
observed that nearly all of the neutrophils present m singk-
cell suspensions obtained from SCCVH tumours are des-
troyed during the preparation of cytospins for the indirect
immunoperoxidase staining. These cells, which are known to
be especially fragile, are too sensitive for the centrifuged
forces used in cytospin preparations.
Because of that problem, separate aliquots of single-cell
suspensions were always taken for Wright staining. Insutead
of cytospin centrifugation, 10,ul of concentrated cell suspen-
sions was gently layered onto glass slides and left to dry
before Wright staining was performed. In this way, neut-
rophils were preserved, and they were easily identified by the
characteristic shape of their nuclei. The number of neut-
rophils in relation to the other immune and non-immune
cells was also determined in these preparations. In addition,
the mast cells were also ientified by the Wright staining. The
above-described combination of the idixrect immunoperox-
idase staining (with neutrophils sctively eliminated) and
Wright Staining of slides speially prepared to preserve neut-
rophils enabled reliable determination of major cellular
populations found in the SCCVH tumour.
The columns in Figure I represent cell yields for main
populations recovered from tumours at indicated times after
the completion of light treatment. Their proportions in the
total cell mass are given in the pie graphs. The data in the
histogram scon demonstrate that the yield of individual
cell populations decreased markedly at 4 h post PDT, and
even more so at 8 h post PDT. However, important changes
were also seen at 0 h (imiately after the termination of
light treatment) and at 2 h post PDT. The most dramatic
oocurrence noted at Oh is a 100-fold incrase in the neut-
rophil content compared with the control tumour. In addi-
tion, the level of 'other myeloid cells' signifintly decreased
relative to the level in the controls at this time point. In
contrast, the neutrophil content dropped maredl at 2 h
post PDT, while the yield of 'other myeloid cells' increased.
All these changes are statistically significnt (P<0.01). They
also affected the proportions among the major cel popula-
tions. As shown in the pie graphs, the percentage of malig-
nant ceUs decreased at 0 h compared with the controls (owing
to markedly increased percentage of neutrophils), but it
decreased even further at 4 h post PDT. More than half of
the cells at this last time point were F4/80+, and there was
also a high proportion (-25%) of 'other myeloid cells'. No
substantial changes in the percentage of T lymphocytes were
seen during the observation period.
The striking changes in neutrophil numbers detected at O h
post PDT prompted us to examine the neutrophil content in
tumours during the photodynamic light treatment. This
analysis (based on Wright stained preparations), which
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Figwe 2 SCCVII tumour contents of neutophils (U) and mast
cells (*) at various times during and after photodynamic lght
delvery (indicated by shaded bar), determined m Wnght-staned
preparations. The PDT treatment was as in Figure 1. The bars
show s.d.
included also mast cells, is shown in Figure 2. As early as
2 min after the onset of light delivery, the number of neut-
rophils incased from 1.6 x 10' g- tumour tissue (control
tumours) to 2.4 x 10'g-I tumour tissue. Three minutes later
the neutrophil klvs were even higher, but at 12 min into the
light delivery (half of the total light dose) they already
showed a marked decline. The neutrophil content then con-
tinued to decrease more slowly. It should be emphasised that
the weight of tumours used in this study was 7-10 times
lower than I g, the weight used conventionally (and also in
the presetaton ofthis data) in the alclations ofcell yields.
It is important to mention this, because the total number of
neutrophils in a mouse is less than 3.2 x 10', the peak level
of these cells that would be contained in a 1 g tumour.
An increase in the number of mast cells was observed at
5 min into the light treatment and continued during the light
delivery and beyond, reaching a peak at 30min post PDT
(Figure 2). A similarly high level ofmast cells was detected at
2 and 4 h after PDT (data not shown). Even at these levels
the mast cell content in the tumours was much lower than
the content of the other cell populations shown in Figure 1,
and thus they could not affect the percentage distributions
given in the pie graphs. It should be noted that the scale for
mast cells (right ordinate in Figure 2) has much lower values
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Fgwe 3 Distribution of Hoechst 33342 fluorescence in represen-
tative SCCVII tumours determined by flow cytometry. The
tumours treated with PDT (as in Figure 1) were excised at 2 h
after the temination of light treatment. The graphs show
Hoechst fluorescence per cell in arbitrary units on the logarithmic
sca (abscissa) and cell number on a hnear scale (ordinate). (a)
Cells from an umped tumour excised from a control mouse
not injected with Hoechst (gate B defining Hoechst-positive cells
and gate E diiting Hoechst negative cells were set in this
graph for all the other cell samples); (b) Cels from an unclamped
control tumour excised from a mouse given Hoechst (c) Cells
from a control tumour that was clamped before the mouse was
given Hoechst (d) Cells from a photodynamic light-treated
tumour that was clamped before the mouse was adminie
Hoechst, but whih had not receivd Photofnn. (e) Cells from an
unclamped tumour treated with Photofrin-based PDT that was
growing in a mouse given Hoechst. (f) Cells from a tumour
treated with Photofrin-based PDT that was clamped before the
mouse was injected with Hochst.
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than the scale for neutrophils (left ordinate), as the levels of
these cells were several logs lower than the neutrophil levels.
Photofrin administered to SCCVII tumour-bearing mice
(24 h earlier) not combined with photodynamic light treat-
ment, or light treatment of tumours in the absence of Photo-
frin administration, produced no effect on the content of
tumour cell populations (data not shown).
Hoechst staining ofcirculating leucocytes
The changes in the cellular populations present within
SCCVII tumours presented in Figures 1 and 2 cannot be
explained without a contribution, at least in part, from newly
amved cells from the circulation. With neutrophils and mast
cells, whose incidence in non-treated tumours is below 1%
(neutrophils) or even below 0.01% (mast cells), their
dramatic increase in the tumour can be explained only by the
infiltration of cells from the circulation. However, the situa-
tion is less clear with cells whose levels in non-treated
tumours are much higher, and a possible PDT-induced
infiltration would not result in a multi-fold increase in their
total tumour content. In such a case, the relative increase in
one type of cells may result also from selective killing of the
other cell types.
In the next series of experiments we used the fluorescent
dye Hoechst to label selectively immune cells in the blood-
stream and to determine their presence in the tumour after
PDT, as described in Materials and methods. The limitation
of this type of experiment is that the time interval between
the Hoechst injection and tumour excision cannot be
extended beyond 2-3 h, because at later times the dye levels
in the labelled cells markedly decreased. Based on this con-
sideration, and on the result indicating a significant increase
in 'other myeloid cells' between 0 and 2 h post PDT (Figure
1), we chose 2 h post PDT as the time point in these
experiments. The combination of Grl and F4/80 antibodies
in the two-colour flow cytometry seemed to us the best
solution for the identification of myeloid cells that are not
mature macrophages. The majority of cells stained as Grl+
F4/80- can be assumed to be monocytes, since we know that
tumour levels of other Gri+ cells (neutrophils and other
granulocytes) at that time interval are low (1-2%). In our
experience, the Grl antibody served better for the iden-
tification of myeloid cells than the Macl; not all Grl+ cells
stained positively for Macl.
The representative examples of Hoechst fluorescence in
cells obtained from differently treated tumours are shown in
Figure 3, while the average values from groups of identically
treated tumours are depicted in Figure 4. With control sam-
ples, it can be seen that around 35% of cells from the
unclamped tumours were Hoechst positive, while only a
small cell fraction from the clamped tumours were within the
gate for Hoechst-positive staining. It seems that the clamping
itself induced a minor influx of Hoechst-positive cells, prob-
ably because of a reaction to temporary vessel occlusion. The
results with the tumours growing in mice not injected with
Photofrin exposed to the photodynamic light treatment were
very similar to those with the control tumours. In the
unclamped PDT-treated tumours, the percentage of Hoechst-
positive cells was similar to that seen with the unclamped
control tumours. In contrast, the level of Hoechst-positive
cells in the clamped PDT-treated tumour (more than 20% of
the cells were newly infiltrated) was much higher than in the
non-treated clamped tumours. This finding demonstrates that
PDT treatment induced infiltration of Hoechst-positive cells
from the circulation. This was not the case with the light
treatment in the absence of the photosensitiser.
The reconstruction of cellular composition of PDT-treated
tumour at 2 h post treatment, showing the contribution of
resident and newly infiltrating cells, is shown in the histo-
gram section of Figure 5. From the data it is evident that
Grl+ F4/80- cells are the major component of the PDT-
induced infiltrate at this time interval. Approximately one-
third of the Grl+ F4/80- cells present in the tumour are
those that invaded after PDT.
The pie graphs in Figure 5 show the percentage distribu-
tion of major cellular populations separately for newly
infiltrated and resident cells. Over 80% of newly infiltrated
cells were Grl+ F4/80-, while -10% were F4/80+. The
values for the percentage of the remaining Hoechst-positive
cells (other CD45', CD45-) were at the levels which fall
within the experimental error, and the presence of these cells
cannot be supported by statistical evaluation. The percentage
distribution of tumour resident cells (Hoechst negative)
shows that the share of malignant cells (CD45-) is very
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(2 h post PDT)
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Fuge 4 Infiltration induced by PDT of Hoechst-labelled cells
from the blood into the SCCVII tumour. Average values are
shown for the clamped and unclamped tumours (shaded and
unshaded columns respectively) exemplified in Figure 3. The bars
are s.d.
CD45- F4/80
Fige 5 The content of various populations among tumour
resident cells (Hoechst negative, X ) and newly infiltrated cells
(Hoechst positive, _) in SCCVII tumours at 2 h post PDT.
Relative contributions of these cell populations are shown in the
pie graphs. The experimental details were as in Figures 3 and 4.
The bars show s.d.
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similar to that in the non-treated tumours (pie graph in
Figure 1). In spite of different methods (indirect immuno-
peroxidase staining vs flow cytometry) and somewhat
different combinations of antibodies used, the results suggest
that the percentage compositon of resident immune cells has
also not drastically changed at 2 h post PDT compared with
the non-treated tumour. Given the fact that the total cell
yield was reduced by approximately half at 2 h after PDT,
these results indicate that the level of killing of different types
of resident leucocytes and malignant cells was similar.
Cvtotoxiciti of TAMs after PDT
The occurrence of a pronounced invasion of leucocytes into
PDT-treated tumour may. together with the other inflam-
matory changes. affect the activity of immune cells directed
against the tumour. To test this, we harvested TAMs con-
tained in SCCVII tumour using a differential attachment
technique employed in our earlier studies (Korbelik et al.,
1991). Staining with monoclonal antibodies showed that over
90% of the cells selected in this way were Mac + and "-70%
were F4 80+. The cytotoxicity of these cells against in vitro
cultured SCCVII malignant cells was examined. The results
(Figure 6) show that TAMs harvested from a PDT treated
SCCVII tumour at 2 h after the treatment were almost five
times more effective in the cytolysis of target cells than the
TAMs from non-treated tumour.
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Fire 6 Cytotoxicty of tumour-associated macrophages
(TAMs), selected from PDT treated and non-treated SCCVII
tumours. against in vitro cultivated SCCVII cells. The cultured
(malignant) SCCVII cells were labelled with [3H]thymidine and
admixed with macrophages harvested from SCCVII tumours as
described in the Materials and methods section. The treatment of
Photofrin-based PDT of SCCVII tumours used for TAMs isola-
tion was as in Figure 1, with the tumour excision performed at
2 h post PDT. The bars show s.d.
Discussion
Dramatic changes occur in the cellular composition of
SCCVII tumours treated with Photofrin-based PDT. The
most striking change is the massive invasion of neutrophils
into the tumour that starts rapidly (within 2 min) after the
onset of photodynamic light treatment. Within 5mn, the
neutrophil content in the treated tumour increased 200-fold,
before decreasing once again to the levels seen in non-treated
tumours between 2 and 4 h after PDT. Mast cells were the
other type of immune cells that started to invade the tumour
very early after the onset of photodynamic light treatment
(within 5 min). The number of these cells in non-treated
SCCVII tumour is very low (about 1000 cells in a 100 mg
tumour) but their levels were more than five times higher
between 0.5 and 4 h after PDT. Mast cells are powerful
mediators of inflammatory response, and their recruitment.
in spite of the low tumour content, could have a pronounced
effect in the PDT-treated tumour.
Selective labelling of circulating leucocytes enabled the
detection of the PDT-induced infiltration by another myeloid
cell type into treated SCCVII tumours between 0 and 2 h
post PDT. These cells expressed the Grl antigen (a common
myeloid cell marker) and most of them stained negatively for
the F4 80 antigen (a marker for mature macrophages). Based
on this fact, and on the morphological examination, we
concluded that the majority of these cells were most likely
monocytes.
The percentage of malignant cells in SCCVII tumour
decreased markedly during the photodynamic light treatment
owing to the massive neutrophil invasion. The proportion of
these cells in the tumour decreased even further during the
next several hours following light delivery because of newly
infiltrating monocytic cells. However, the total number of
malignant cells in the tumour started to decrease substan-
tially only after 2 h post PDT, presumably because of rapidly
developing tumour tissue ischaemia (Henderson et al.. 1985).
The results based on the identification of resident malig-
nant and immune cells in SCCVII tumour in the experiments
with Hoechst suggest that within the first 2 h after PDT all
these cells exhibit a similar sensitivity to the lethal effects of
PDT. The only exception may be the inactivation of
monocytes, suggested by the reduction in tumour content of
'other myeloid cells' observed at 0 h post PDT. A fast disap-
pearance of newly infiltrated neutrophils from the treated
tumour indicates that these cells were killed relatively
quickly. These cells as well as 'other myeloid cells' might
have been localised in the area of tumour vasculature already
extensively damaged during the light treatment. In contrast,
the percentage distribution of cellular populations at 4 h post
PDT (pie graph in Figure 1) implies that newly infiltrated
monocytes may outlive most of the tumour resident cells.
Taken together, the above results portray a typical
scenario of acute inflammatory infiltration of myeloid cells at
the affected site. The rapid and massive neutrophil invasion is
promptly accompanied by the arrival of mast cells. Massive
release of chemotactic substances from degranulating mast
cells (Kerdel et al., 1987) and dying neutrophils. as well as
from damaged membranes of tumour cells (alluded to in the
introduction), is the probable impelling force behind another
wave of infiltration, this time involving monocytes, that fol-
lows 1-2 h later. There was no evidence for the participation
of lymphocytes in these PDT-induced tumour infiltration
events during the observation period of this study (up to 8 h
post PDT).
The inflammatory reaction in PDT-treated tumour appears
to have similarities with the cutaneous inflammation.
identified as the main factor in PDT-induced skin phototox-
icity, in which neutrophils and mast cells also have a critical
role (Lim, 1989).
The data demonstrating a pronounced increase in the
tumoricidal activity of TAMs (Figure 6) offer evidence that
this inflammatory response is actually associated with the
functional activation of immune cells. In a related study with
cultured macrophages and tumour cells, we have demon-
strated that in vitro PDT treatment of tumour cells (but not
normal cells) potentiates their killing by macrophages
(Korbelik and Krosl, 1994). The implication is that poten-
tially reparable damage induced by PDT in tumour cells
triggers macrophage-mediated tumoricidal activity. Such
activity of non-specific immune cells may lead in a later
phase to the development of a T-cell-specific immune activity.
The ingestion of PDT-damaged or -killed tumour cells by
macrophages, which are antigen-presenting cells, can result in
tumour antigen presentation, with the consequent induction
of tumour specific immunity (Yamamoto et al., 1992). Such a
development of PDT-induced immunopotentiation is sug-
gested by the work of Canti et al. (1994). A number of
reports have documented enhancement of tumour control by
combining PDT with a variety of immunotherapy regimens
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(Myers et al.. 1989; BeUlnier, 1991; Dougherty et al., 1992;
Dima et al., 1994; Krosl and Korbelik, 1994). This supports
the idea that PDT-induced immune reaction may be
amplified and directed towards more effective tumour des-
truction.
Much work remains to be done in exploring the effects of
PDT on cellular composition of tumours treated with
different Photofrin/light dose combinations, examining the
effects in different tumour models and with other photosen-
sitisers. Each of these aspects requires a substantial experi-
mental effort.
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